CASI Pharmaceuticals Statistics
Total Valuation
CASI has a market cap or net worth of $31.22 million. The enterprise value is $37.27 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CASI has 15.49 million shares outstanding. The number of shares has increased by 14.82% in one year.
| Current Share Class | 15.49M |
| Shares Outstanding | 15.49M |
| Shares Change (YoY) | +14.82% |
| Shares Change (QoQ) | +25.22% |
| Owned by Insiders (%) | 13.05% |
| Owned by Institutions (%) | 5.76% |
| Float | 7.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.08 |
| Forward PS | 5.02 |
| PB Ratio | 16.87 |
| P/TBV Ratio | 19.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 11.96.
| Current Ratio | 1.09 |
| Quick Ratio | 0.86 |
| Debt / Equity | 11.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.02 |
Financial Efficiency
Return on equity (ROE) is -301.80% and return on invested capital (ROIC) is -70.63%.
| Return on Equity (ROE) | -301.80% |
| Return on Assets (ROA) | -38.01% |
| Return on Invested Capital (ROIC) | -70.63% |
| Return on Capital Employed (ROCE) | -227.69% |
| Revenue Per Employee | $122,476 |
| Profits Per Employee | -$168,489 |
| Employee Count | 233 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.72% in the last 52 weeks. The beta is 0.61, so CASI's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -19.72% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 4.35 |
| Relative Strength Index (RSI) | 45.94 |
| Average Volume (20 Days) | 13,092 |
Short Selling Information
The latest short interest is 19,082, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 19,082 |
| Short Previous Month | 23,246 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.26% |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, CASI had revenue of $28.54 million and -$39.26 million in losses. Loss per share was -$2.56.
| Revenue | 28.54M |
| Gross Profit | 11.15M |
| Operating Income | -39.21M |
| Pretax Income | -27.02M |
| Net Income | -39.26M |
| EBITDA | -36.88M |
| EBIT | -39.21M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $16.09 million in cash and $22.14 million in debt, giving a net cash position of -$6.05 million or -$0.39 per share.
| Cash & Cash Equivalents | 16.09M |
| Total Debt | 22.14M |
| Net Cash | -6.05M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 1.85M |
| Book Value Per Share | 0.12 |
| Working Capital | 3.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.22 million and capital expenditures -$223,000, giving a free cash flow of -$29.45 million.
| Operating Cash Flow | -29.22M |
| Capital Expenditures | -223,000 |
| Free Cash Flow | -29.45M |
| FCF Per Share | -$1.90 |
Full Cash Flow StatementMargins
Gross margin is 39.06%, with operating and profit margins of -137.41% and -137.57%.
| Gross Margin | 39.06% |
| Operating Margin | -137.41% |
| Pretax Margin | -137.57% |
| Profit Margin | -137.57% |
| EBITDA Margin | -129.24% |
| EBIT Margin | -137.41% |
| FCF Margin | n/a |
Dividends & Yields
CASI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.82% |
| Shareholder Yield | -14.82% |
| Earnings Yield | -125.76% |
| FCF Yield | -94.33% |
Analyst Forecast
The average price target for CASI is $4.00, which is 98.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 98.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -10.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 2, 2022. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jun 2, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
CASI has an Altman Z-Score of -19.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.27 |
| Piotroski F-Score | 2 |